본문 바로가기
KERD
논문KCI 등재

Chronic Placental Inflammation as a Risk Factor of Severe Retinopathy of Prematurity

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: Chronic placental inflammation (CPI) has been implicated in the pathogenesis of diseases in premature infants, whereas retinopathy of prematurity (ROP) is a major complication primarily affecting preterm and very low-birth-weight (VLBW) infants. This study aims to investigate the association between CPI and ROP in VLBW infants. Methods: We performed a retrospective review of clinical records of VLBW infants born between 2013 and 2016. Placental pathology findings including CPI cases were analyzed using logistic regression to study infants’ morbidities and other clinical characteristics. Results: A total of 402 infants with a mean (standard deviation) gestational age of 28.5 (2.8) weeks and birth weight of 1,027.2 (304.4) g were included. The incidence of ROP was 24.1%. CPI was found in 90 infants (22.4%), among which 28.9% (26 of 90) developed ROP, and 21.1% (19 of 90) underwent laser photocoagulation. Lower gestational age, lower birth weight, longer duration of oxygen supply, and presence of CPI were associated with the development of ROP. After adjustment for gestational age, birth weight, sex, duration of oxygen supply, and other overlapping placental pathology, CPI was associated with the odds for type 1 ROP that required laser photocoagulation (adjusted odds ratio, 2.739; 95% confidence interval, 1.112 to 6.749; p = .029). Conclusions: CPI was associated with severe ROP requiring treatment with laser photocoagulation in VLBW infants.

Abstract

Background: Chronic placental inflammation (CPI) has been implicated in the pathogenesis of diseases in premature infants, whereas retinopathy of prematurity (ROP) is a major complication primarily affecting preterm and very low-birth-weight (VLBW) infants. This study aims to investigate the association between CPI and ROP in VLBW infants. Methods: We performed a retrospective review of clinical records of VLBW infants born between 2013 and 2016. Placental pathology findings including CPI cases were analyzed using logistic regression to study infants’ morbidities and other clinical characteristics. Results: A total of 402 infants with a mean (standard deviation) gestational age of 28.5 (2.8) weeks and birth weight of 1,027.2 (304.4) g were included. The incidence of ROP was 24.1%. CPI was found in 90 infants (22.4%), among which 28.9% (26 of 90) developed ROP, and 21.1% (19 of 90) underwent laser photocoagulation. Lower gestational age, lower birth weight, longer duration of oxygen supply, and presence of CPI were associated with the development of ROP. After adjustment for gestational age, birth weight, sex, duration of oxygen supply, and other overlapping placental pathology, CPI was associated with the odds for type 1 ROP that required laser photocoagulation (adjusted odds ratio, 2.739; 95% confidence interval, 1.112 to 6.749; p = .029). Conclusions: CPI was associated with severe ROP requiring treatment with laser photocoagulation in VLBW infants.

참고문헌 (40)

  1. Galinsky R, "The consequences of chorioamnionitis: preterm birth and effects on development", J Pregnancy, 2013, pp.412831~ (2013)
  2. Morgan TK, "Role of the placenta in preterm birth: a review", Am J Perinatol, 33, pp.258~266 (2016)[DOI]
  3. Redline RW, "Placental pathology: a systematic approach with clinical correlations", Placenta, 29(Suppl A), pp.S86~S91 (2008)[DOI]
  4. Lee J, "Chronic chorioamnionitis is the most common placental lesion in late preterm birth", Placenta, 34, pp.681~689 (2013)[DOI]
  5. Kim CJ, "Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance", Am J Obstet Gynecol, 213(4 Suppl), pp.S29~S52 (2015)[DOI]
  6. Kim CJ, "The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth", Mod Pathol, 23, pp.1000~1011 (2010)[DOI]
  7. Martin RJ, "Fanaroff and Martin's neonatal-perinatal medicine" (2014), Elsevier Health Sciences
  8. Liu PM, "Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g", Am J Perinatol, 22, pp.115~120 (2005)[DOI]
  9. Lee J, "Perinatal infection, inflammation, and retinopathy of prematurity", Semin Fetal Neonatal Med, 17, pp.26~29 (2012)[DOI]
  10. Woo SJ, "Effects of maternal and placental inflammation on retinopathy of prematurity", Graefes Arch Clin Exp Ophthalmol, 250, pp.915~923 (2012)[DOI]
  11. Redline RW, "Placental diagnostic criteria and clinical correlation: a workshop report", Placenta, 26(Suppl A), pp.S114~S117 (2005)[DOI]
  12. Kim CJ, "Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance", Am J Obstet Gynecol, 213(4 Suppl), pp.S53~S69 (2015)[DOI]
  13. Redline RW, "Classification of placental lesions", Am J Obstet Gynecol, 213(4 Suppl), pp.S21~S28 (2015)[DOI]
  14. International Committee for the Classification of Retinopathy of Prematurity, "The International Classification of Retinopathy of Prematurity revisited", Arch Ophthalmol, 123, pp.991~999 (2005)[DOI]
  15. Early Treatment for Retinopathy of Prematurity Cooperative Group, "Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial", Arch Ophthalmol, 121, pp.1684~1694 (2003)[DOI]
  16. Romero R, "The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology", Am J Obstet Gynecol, 166, pp.1382~1388 (1992)[DOI]
  17. Mechoulam H, "Retinopathy of prematurity: molecular pathology and therapeutic strategies", Am J Pharmacogenomics, 3, pp.261~277 (2003)
  18. Hansen RM, "The neural retina in retinopathy of prematurity", Prog Retin Eye Res, 56, pp.32~57 (2017)[DOI]
  19. Smith LE, "Pathogenesis of retinopathy of prematurity", Growth Horm IGF Res, 14(Suppl A), pp.S140~S144 (2004)[DOI]
  20. Chen J, "Retinopathy of prematurity", Angiogenesis, 10, pp.133~140 (2007)[DOI]
  21. Tasman W, "Retinopathy of prematurity: the life of a lifetime disease", Am J Ophthalmol, 141, pp.167~174 (2006)[DOI]
  22. Hartnett ME, "Role of cytokines and treatment algorithms in retinopathy of prematurity", Curr Opin Ophthalmol, 28, pp.282~288 (2017)[DOI]
  23. Flynn JT, "A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity", N Engl J Med, 326, pp.1050~1054 (1992)[DOI]
  24. Dammann O, "Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis", Early Hum Dev, 85, pp.325~329 (2009)[DOI]
  25. Sood BG, "Perinatal systemic inflammatory response syndrome and retinopathy of prematurity", Pediatr Res, 67, pp.394~400 (2010)[DOI]
  26. Kobayashi H, "Angiogenesis links chronic inflammation with cancer", Methods Mol Biol, 511, pp.185~191 (2009)
  27. Folkman J, "Angiogenesis", J Biol Chem, 267, pp.10931~10934 (1992)
  28. Voronov E, "IL-1 is required for tumor invasiveness and angiogenesis", Proc Natl Acad Sci U S A, 100, pp.2645~2650 (2003)[DOI]
  29. Costa C, "Angiogenesis and chronic inflammation: cause or consequence?", Angiogenesis, 10, pp.149~166 (2007)[DOI]
  30. Hellstrom A, "Postnatal serum insulinlike growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth", Pediatrics, 112, pp.1016~1020 (2003)[DOI]
  31. Connor KM, "Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis", Nat Med, 13, pp.868~873 (2007)[DOI]
  32. Najm S, "Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial", Clin Nutr ESPEN, 20, pp.17~23 (2017)[DOI]
  33. Romero R, "CXCL10 and IL-6: Markers of two different forms of intra-amniotic inflammation in preterm labor", Am J Reprod Immunol, 78, pp.e12685~ (2017)[DOI]
  34. Romagnani P, "CXC chemokines: the regulatory link between inflammation and angiogenesis", Trends Immunol, 25, pp.201~209 (2004)[DOI]
  35. Lazzeri E, "High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy", Transplantation, 79, pp.1215~1220 (2005)[DOI]
  36. Lynch AM, "The relationship of the subtypes of preterm birth with retinopathy of prematurity", Am J Obstet Gynecol, 217, pp.354.e1~354.e8 (2017)[DOI]
  37. Powe CE, "Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease", Circulation, 123, pp.2856~2869 (2011)[DOI]
  38. Taylor RN, "Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies", Am J Obstet Gynecol, 188, pp.177~182 (2003)[DOI]
  39. Zhu T, "Association of maternal hypertensive disorders with retinopathy of prematurity: a systematic review and meta-analysis", PLoS One, 12, pp.e0175374~ (2017)[DOI]
  40. Luttun A, "Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders", Ann N Y Acad Sci, 979, pp.80~93 (2002)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (11건)